A data analysis found the inhaled therapy Tyvaso outperformed a placebo at preserving lung function in people with IPF in a ...
A critically ill 33-year-old man survived an almost unimaginable scenario—living for 48 hours without lungs—thanks to a groundbreaking surgical approach. After a severe flu-triggered infection ...
RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...
Regan Sparks, a 23-year-old British woman with cystic fibrosis, has been denied entry into Australia twice, first on a ...
Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.
After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...
Trikafta, a ‘miracle’ cystic fibrosis drug, has the potential to radically improve lung function and life expectancy for patients living with the condition. However, it remains inaccessible for ...
Paid content is paid for and controlled by an advertiser and produced by the Guardian Labs team. Scientists at Queen’s University Belfast played a key role in clinical trials that proved that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results